“The CIA requires all current and former Agency employees and contractors, and others who are obligated by CIA secrecy agreement, to submit for prepublication review to the CIA’s Publications Review Board (PRB) all intelligence-related materials intended for publication or public dissemination,” according to a 2007 regulation (pdf) on the subject.
The scope of the requirement, according to CIA, is expansive. It “includes, but is not limited to, works of fiction; books; newspaper columns; academic journal articles; magazine articles;… letters to the editor;… scripts; screenplays; internet blogs, emails, or other writings;” and so forth.
A redacted version of the latest version of the CIA regulation was released in response to a Freedom of Information Act lawsuit filed by the James Madison Project, a non-profit advocacy organization. The Project’s director, attorney Mark S. Zaid, frequently litigates pre-publication review disputes against the CIA.
The text of the regulation, “Agency Prepublication Review of Certain Material Prepared for Public Dissemination,” 30 May 2007, is here.
Related background on CIA prepublication review policy, including a (redacted) handbook for agency reviewers (pdf), can be found on this page.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.